William Osler Health System Brampton Civic Hospital
Brampton, Ontario, Canada
Hospital in Brampton, Ontario
2100 Bovaird Dr E, Brampton, ON L6R 3J7
608 Beds
About William Osler Health System Brampton Civic Hospital
Brampton Civic Hospital is an acute care hospital in Brampton, Ontario and part of the William Osler Health System. It is a community teaching hospital for the Michael G. DeGroote School of Medicine of McMaster University.
There are 608 beds in William Osler Health System Brampton Civic Hospital.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Gilead Sciences
3
National Cancer Institute (NCI)
2
University Health Network, Toronto
2
C. R. Bard
1
Galectin Therapeutics Inc.
1
Inventiva Pharma
1
Janssen Research & Development, LLC
1
PhaseBio Pharmaceuticals Inc.
1
Sunnybrook Health Sciences Centre
1
The Hospital for Sick Children
1
Clinical Trials at William Osler Health System Brampton Civic Hospital
During the past decade, William Osler Health System Brampton Civic Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 5 clinical trials were completed, i.e. on
average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
2012-08-24
2016-09-16
Completed
572
Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease
2017-03-22
2018-11-07
Completed
59
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
2017-02-13
2019-06-19
Terminated
808
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
2017-01-30
2019-05-06
Terminated
883
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
2017-09-22
2024-04-27
Recruiting
1,000
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
2019-03-12
2024-04-30
Active, not recruiting
600
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "William Osler Health System Brampton Civic Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Gilead Sciences" with 3 trials
sponsored, "National Cancer Institute (NCI)" with 2 trials sponsored, "University Health Network, Toronto" with 2 trials sponsored and "C. R. Bard"
with 2 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "William Osler Health System Brampton Civic Hospital"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Apotex Inc." with 1 trials as a collaborator, "Applied Health Research Centre" with 1 trials as a collaborator and "Arch Biopartners Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at William Osler Health System Brampton Civic Hospital
According to Clinical.Site data, the most researched conditions in "William Osler Health System Brampton Civic Hospital" are
"COVID-19" (2 trials), "NASH - Nonalcoholic Steatohepatitis" (2 trials), "Nonalcoholic Steatohepatitis" (2 trials), "Acute Respiratory Distress Syndrome" (1 trials) and "Ann Arbor Stage III Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "William Osler Health System Brampton Civic Hospital" in a lesser frequency.
Clinical Trials Intervention Types at William Osler Health System Brampton Civic Hospital
Most popular intervention types in "William Osler Health System Brampton Civic Hospital" are "Drug" (16 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Docetaxel" (3 trials), "Computed Tomography" (2 trials), "Dexamethasone" (2 trials) and "Magnetic Resonance Imaging" (2 trials). Other intervention names were less common.
Clinical Trials Genders at William Osler Health System Brampton Civic Hospital
The vast majority of trials in "William Osler Health System Brampton Civic Hospital" are
20 trials for "All" genders.
Clinical Trials Status at William Osler Health System Brampton Civic Hospital
Currently, there are NaN active trials in "William Osler Health System Brampton Civic Hospital".
undefined are not yet recruiting,
7 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in William Osler Health System Brampton Civic Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in William Osler Health System Brampton Civic Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".